key: cord-0271381-o39hxg83
authors: Yang, Ning; Wang, Yi; Dai, Peihong; Li, Tuo; Zierhut, Christian; Tan, Adrian; Zhang, Tuo; Pan, Heng; Li, Zhuoning; Ordureau, Alban; Xiang, Jenny Zhaoying; Hendrickson, Ronald C.; Funabiki, Hironori; Chen, Zhijian; Deng, Liang
title: Vaccinia E5 is a major inhibitor of the DNA sensor cGAS
date: 2021-10-26
journal: bioRxiv
DOI: 10.1101/2021.10.25.465197
sha: df67d10c176d80068336d51d78f7bae3c43739b6
doc_id: 271381
cord_uid: o39hxg83

The DNA sensor cyclic GMP-AMP synthase (cGAS) is critical in host antiviral immunity. Vaccinia virus (VACV) is a large cytoplasmic DNA virus that belongs to the poxvirus family. How vaccinia virus antagonizes the cGAS-mediated cytosolic DNA-sensing pathway is largely unknown. In this study, we screened 82 vaccinia viral genes to identify potential viral inhibitors of the cGAS/Stimulator of interferon gene (STING) pathway. We discovered that vaccinia E5 is a virulence factor and a major inhibitor of cGAS that elicits proteasome-dependent cGAS degradation. E5 localizes to the cytoplasm and nuclei of infected cells. Cytosolic E5 triggers K48-linked ubiquitination of cGAS and proteasome-dependent degradation via interacting with cGAS. E5 itself also undergoes ubiquitination and degradation. Deleting the E5R gene from the Modified vaccinia virus Ankara (MVA) genome strongly induces type I IFN production by dendritic cells (DCs) and promotes DC maturation, thereby improving the immunogenicity of the viral vector.

The DNA sensor cyclic GMP-AMP synthase (cGAS) is critical in host antiviral immunity. 24

Vaccinia virus (VACV) is a large cytoplasmic DNA virus that belongs to the poxvirus family. 25

How vaccinia virus antagonizes the cGAS-mediated cytosolic DNA-sensing pathway is largely 26 unknown. In this study, we screened 82 vaccinia viral genes to identify potential viral inhibitors 27 of the cGAS/Stimulator of interferon gene (STING) pathway. We discovered that vaccinia E5 is 28 a virulence factor and a major inhibitor of cGAS that elicits proteasome-dependent cGAS 29 degradation. E5 localizes to the cytoplasm and nuclei of infected cells. Cytosolic E5 triggers In this study, we performed a screen of 82 vaccinia viral genes for inhibition of the cGAS/STING 68 pathway using a dual-luciferase reporter assay and identified several vaccinia genes encoding 69 proteins involved in down-regulating the cGAS/STING/IFNB pathway. Here we show that E5 70 (encoded by the E5R gene), a BEN-domain-containing protein conserved among orthopoxviruses, 71 is a virulence factor and a major inhibitor of cGAS. E5 interacts with cytoplasmic cGAS and 72 triggers its degradation in a proteasome-dependent manner. To identify potential cGAS inhibitors from the vaccinia genome, we first selected 82 viral genes, 86 mainly the ones expressed at early times during vaccinia infection (Yang et al., 2010) , with the 87 reasoning that antagonists of innate immunity are likely encoded by viral early genes. A dual-88 luciferase assay was then performed to screen for the abilities of these viral proteins to inhibit the 89 cGAS/STING-mediated cytosolic DNA-sensing pathway. Briefly, HEK293T-cells were 90 transfected with plasmids expressing an IFNB-firefly luciferase reporter, a pRL-TK control 91 plasmid expressing Renilla luciferase, murine cGAS, human STING, and individual vaccinia viral 92 genes as indicated ( Figure 1C ). Adenovirus E1A, which inhibits this pathway via interaction with 93 STING (Lau et al., 2015) , was used as a positive control for this screening assay ( Figure 1C ). This 94 assay identified several vaccinia viral early genes (E5R, K7R, B14R, C11R, WR199/B18R, 95 WR200/B19R, E4L) as potential inhibitors of the cGAS/STING pathway ( Figures 1C and 1D) . 96

Over-expression of all of the candidates except B14R had little effects on STING-induced IFNB 97 promoter activity, suggesting that B14 might target STING or its downstream signaling pathways 98 while other candidates might target cGAS ( Figure 1E ). Among these genes, WR200/B19R is 99 known to encode a type I IFN binding protein (Symons et al., 1995 cowpox viruses contain an extra 10-amino acid sequence at the N-termini compared with E5 137 proteins from vaccinia (Ankara), MVA, and ectromelia (mousepox) ( Figure S1C ). Interestingly, 138

Monkeypox E5 has large deletions at both its N-and C-termini ( Figure S1C , (Douglas and 139 Dumbell, 1996) . 140 141

To test whether vaccinia E5 is a virulence factor, we performed an intranasal infection experiment 143

with WT VACV or VACV∆E5R (2 x 10 6 pfu) in WT C57BL/6J mice. All of the mice infected 144 with WT VACV lost weight quickly, starting on the third day of infection, and either died or were 145 euthanized due to more than 30% weight loss at days 7 to 8 post-infection (Figures 2A and 2B) . 146

By contrast, mice infected with VACV∆E5R lost close to 15% of initial body weight on average 147 at day 6 post-infection, and then recovered (Figures 2A and 2B ). These results indicate that 148 VACV∆E5R is attenuated compared with WT VACV and thereby demonstrate that E5 is a 149 virulence factor. Furthermore, VACV∆E5R (2 x 10 7 pfu) gained virulence in cGas -/-, or Sting gt/gt 150 mice but remained attenuated in Mda5 -/mice, indicating the cytosolic DNA-sensing pathway 151 mediated by cGAS or STING is indispensable for host defense against intranasal infection with 152 VACV∆E5R ( Figure 2C To determine which domain(s) of E5 are required for E5-mediated inhibition of IFNB induction 157 and virulence, we constructed VACV-E5R (full-length) and a series of its truncation mutants, as 158 shown in Figure 2F . Whereas VACV-E5R (full-length) only mildly induced IFNB gene expression 159 in BMDC cells ( Figure 2G ), all E5R truncation mutants induced IFNB gene expression at a similar 160 level to VACV∆E5R ( Figure 2G ). Moreover, intranasal infection of VACV-E5R (full-length) and 161 E5R truncation mutants (2 x 10 7 pfu) in C57BL/6J mice showed that only VACV-E5R (full-length) 162 infection was lethal, while all of the truncation mutants caused transient weight loss but 100% 163 survival, except for VACV-E5R∆224N (with 80% survival) ( Figure 2H and 2I Figure 3A ), whereas MVA infection had 171 modest induction. MVA∆E5R infection of BMDCs induced much higher levels of IFN-b secretion 172 than MVA, or heat-inactivated MVA (heat-iMVA), or heat-inactivated MVA∆E5R (heat-173 iMVA∆E5R) ( Figure 3B ). In addition, heat-iMVA∆E5R caused higher levels of IFN-b secretion 174 than heat-iMVA ( Figure 3B ). Heat-inactivation at 55˚C for one hour prevents viral protein 175 expression in infected cells (Dai et al., 2017) . Therefore the difference in IFN-b induction between 176 heat-iMVA∆E5R and heat-iMVA-infected DCs might be attributed to virion E5 protein brought To investigate how E5 antagonizes the cGAS/STING pathway, we first evaluated cGAS protein 205 levels after WT VACV infection. We observed that cGAS protein levels were lower at six hours 206 after WT VACV infection in BMDCs compared with mock-infection control ( Figure 4A decline of cGAS levels was fully reversed by MG132 and partially reversed by CHX ( Figure 4D ). 218

In contrast, PAA did not affect MVA-caused reduction of cGAS levels, suggesting that the 219 degradation of cGAS is independent of viral DNA replication ( Figure 4D ). 220 221 Using MEFs that express GFP-cGAS, in which GFP was tagged to the N-terminus of cGAS, we 222 observed that at 6 h after MVA-mCherry infection, cytoplasmic cGAS was not detectable in 223 mCherry + MVA-infected cells. However, nuclear cGAS remained in those infected cells, 224

suggesting that MVA infection triggered the degradation of only cytoplasmic cGAS ( Figure 4E) . indicating that the cytoplasmic E5 is sufficient to induce cGAS degradation and to suppress type I 238 IFN production. 239 240

To test whether E5 alone can trigger cGAS degradation without viral infection, we co-transfected 243 a cGAS-expressing plasmid with an E5R-expressing plasmid or empty vector. 24 h later, cells 244

were infected with MVADE5R at a MOI of 10 for 6 h in the presence or absence of CHX. We 245 observed that the cGAS level was decreased after co-transfection with the former but not the latter 246 that E5 and cGAS co-localization to punctate cytoplasmic structures ( Figure 5C ). 257

258 We next hypothesized that vaccinia E5 induces cGAS ubiquitination and subsequent proteasome-259 dependent degradation. We detected higher levels of cGAS ubiquitination, particularly K48-linked 260 poly-ubiquitination, in cells infected with MVA compared with those infected with MVA∆E5R 261 ( Figure 5D ). Thus, our results support that E5 expressed by MVA promotes K48-linked poly-262 ubiquitination of cGAS, leading to its degradation. 263

To test whether E5 binds to DNA, we used an in vitro transcription/translation system including 265 reticulocyte lysate, T7 RNA polymerase, and 35 S-methionine. Radio-labeled cGAS or E5 proteins 266

were tested for DNA binding by using DNA-coupled beads. Both cGAS and E5 could be pulled We next engineered a recombinant MVA with a human immunoglobulin (IgG) Fc domain-tagged 282 to the C-terminus of E5, showing that E5-Fc protein was pulled down by protein A agarose. 283

Subsequently, ubiquitinated E5 was determined by western blot using an anti-HA antibody, thus 284 suggesting that E5 is ubiquitinated after viral infection ( Figure 6C ). We show that E5 mediates cGAS degradation via a proteasome-dependent pathway. We propose 344 the following working model based on our results ( Figure 6D ). Vaccinia virus enters host cells via 345 micropinocytosis (Mercer and Helenius, 2008) . Upon viral entry, viral DNA is detected by the 346 cytosolic DNA sensor cGAS, whose activation leads to cGAMP production and subsequent 347 STING stimulation. However, in the presence of vaccinia E5, which is mainly synthesized by the 348 incoming virions as an early viral protein, cGAS is targeted for ubiquitination and proteasome-349 dependent degradation through interacting with E5. This leads to reduced cGAMP production and 350 Various other deletion mutants, including VACV∆B2R, VACV∆E3L, VACV∆C11R, 565 VACV∆WR199, VACV∆WR200, VACV∆K7R, VACV∆B14R, and VACV∆C7L were 566 generated following a procedure similar to that described above. VACV∆E5R-E5R-Flag was 567 generated by inserting the E5R-Flag sequence into the TK locus of VACV∆E5R. VACV-E5R-FL, 568 VACV-E5R∆59N, VACV-E5R∆106N, VACV-E5R∆224N, VACV-E5R∆117C and VACV-569 E5R∆235C were generated by inserting full-length or truncated E5R into the E5R locus of 570 VACV∆E5R. MVA∆E5R and MVA∆E5R-OVA expressing mCherry was generated through 571 homologous recombination at the E4L and E6R loci flanking E5R gene of the MVA or MVA-572 OVA genome in BHK21 cells following a procedure similar to that described above. MVA∆E5R-573 E5R-Fc was generated by inserting E5R-Fc sequence into the TK locus of MVA∆E5R using 574 fluorescence color selection. MVA-E5R-mCherry was generated by inserting E5R-mCherry 575 sequence into the TK locus of MVA. MVA∆E5R-E5 R95K -Flag was generated by inserting E5R-576

Flag sequence into the TK locus of MVA∆E5R using drug selection. The recombinant virus was 577 enriched in the presence of gpt selection medium including MPA, xanthine and hypoxanthine, and 578 plaque purified for at least four rounds. During the selection process, a spontaneous mutation 579 occurred resulting in the generation of MVA∆E5R-E5 R95K -Flag, verified by PCR and DNA 580 sequencing. 581

Female C57BL/6J mice between 6 and 8 weeks of age (5-10 in each group) were anesthetized and 583 infected intranasally with WT VACV, VACV∆E5R or VACV∆E5 expressing E5R full-length 584 revertant and various E5R truncation mutants at the indicated doses in 20 µl PBS. Mice were 585 monitored and weighed daily. Those that lost over 30% of their initial weight were euthanized. Mice epidermal sheet were removed as previously described (Deng et al., 2008) . Briefly, skins 625

were washed with cold Ca 2+ and Mg 2+ free PBS and then incubated in a digestion buffer 626 containing 1 U dispase/ml at 37˚C for 1 h. Epidermal sheets were mechanically removed, the 627 remaining dermis was washed in Ca 2+ and Mg 2+ free PBS 5 times and incubated in a digestion 628 buffer containing 2 mg/ml collagenase A (Roche), 100 µg/ml of DNase I (Sigma; d4527) and 1% 629 BSA in Ca 2+ and Mg 2+ free PBS at 37˚C for 1-2 hours. The resulting suspension was filtered 630 through a 100-, 70-and 40-mm nylon mesh sequentially (VWR) and washed two times with a 631 buffer (Ca 2+ and Mg 2+ free PBS containing 1% BSA and 2 mM EDTA). Cells were cultured 632 RPMI-1640 medium supplemented with 10% fetal bovine serum (FBS). Only the adherent cells 633

were used after 2-3 days of culture. 634

The IFN-β levels in BALF were determined using mouse IFN beta ProQuantum Immunoassay kit 636 into cell lysate to a final concentration of 1 μg/ml and incubated at 4 °C overnight on a rotator. 708

The next day, protein G-magnetic beads (Bio-Rad, 161-4023) were added and incubated at 4 °C 709 for 2 h. The beads were washed five times with RIPA buffer. Lastly, the bead-bound proteins were 710 denatured in SDS buffer by heating at 98 °C for 5 min before loading on an SDS-PAGE gel. E5 711 ubiquitination assays were performed following a procedure similar to those described above. 712

Generally, after HEK293T cells were transfected with HA-Ub, they were then infected with 713 MVA∆E5R or MVA∆E5R-E5R-Fc at MOI 10 for 6 h. After cell lysis with RIPA buffer, protein 714 A-Agarose beads (ThermoFisher, 20333) were added and incubated at 4 °C for 2 h, washed five 715 times, and the bead-bound proteins were denatured in SDS buffer by heating at 98 °C for 5 min 716 before loading on an SDS-PAGE gel. 717 718

Total RNA was extracted from whole cell lysates using TRIzol reagent (Invitrogen) or with 720 RNeasy Plus Mini kit (Qiagen). RNAs were reverse-transcribed and amplified by PCR using the 721 Verso cDNA synthesis kit (Thermo Fisher) and SYBR TM Green Master Mix (Thermo Fisher). 722 Cellular RNAs were normalized to GAPDH levels. All assays were performed on an ABI 7500 723 system and analyzed with ABI 7500 SDS software v.1.3 (Applied Biosystems). Primer sequences 724 used are listed in Table S1 . 725 726

Beads coupled to single-end biotinylated DNA were generated as previously described (Postow et were supplemented with 80 fmol internal standard ( 15 N10-cGAMP, in-house generated) and were 741 extracted subsequently in 80% methanol and 2% acetic acid, and twice in 2% acetic acid to 742 obtain metabolite extract. cGAMP was enriched from combined extracts on HyperSep 743

Aminopropyl SPE Columns (Thermo Scientific). After washing twice in 2% acetic acid and once 744 in 80% methanol, samples were eluted in 4% ammonium hydroxide in 80% methanol. Vacuum-745 dried eluents were dissolved in water and analyzed on a Dionex U3000 HPLC coupled with TSQ The resulting FASTQ files were processed using kallisto (PMID: 27043002) followed by a 795 tximport (PMID: 26925227) transcript-to-gene level transformation. Transcript indices for kallisto 796 were created using FASTA files from Ensembl release 95 for mm10 for all annotated cDNA and 797 ncRNA transcripts, as well as FASTA sequences for WT VACV transcripts (accession no. 798 NC_006998.1). Gene-level read counts were then processed using the limma suite of tools (PMID: 799 25605792) first with a voom transformation, followed by linear model fitting to determine 800 differentialy expressed genes, and lastly performing gene set testing using the CAMERA function. 801

Select gene sets were plotted as row normalized z-scores in heatmaps using voom normalized 802 counts. 803 804

Two-tailed unpaired Student's t test was used for comparisons of two groups in the studies. 806

Survival data were analyzed by log-rank (Mantel-Cox) test. The p values deemed significant are 807 indicated in the figures as follows: *, p < 0.05; **, p < 0.01; ***, p < 0.001; ****, p < 0.0001. The 808

numbers of animals included in the study are discussed in each figure legend. 809

and 600 nL/min (19-27 min), with a gradient of 20% B (0-3 min), 50% B (4 min

19-27 min). cGAMP and standard were analyzed by multiple 752 reaction monitoring in the positive mode with the following transitions: 675-136, 675-152, 675-753 476, and 675-524 for cGAMP; and 685-136, 685-157, 685-480, and 685-529 for the 15 N10-754 cGAMP standard. Endogenous cGAMP levels were calculated by multiplying the cGAMP-to-755

Detection of ubiquitinated vaccinia viral proteins by LC-MS

To detect ubiquitinated viral protein during vaccinia virus infection, HEK293T cells were infected 759 with MVA at MOI 10 for 6 h in the presence of MG132. Ubiquitinated proteins were purified 760 using Halo-4× UBA UBQLN1 as previously described

mg) that were lysed in lysis buffer containing 100 mM chloroacetamide and incubated 762 at 4 °C for 16 h with 30 μL of Halo-4× UBA UBQLN1 beads (pack volume)

ng/µl) on beads at 37˚C for 2 hours followed by incubation at 24˚C 768 overnight. After de-salting, samples were subjected to reduction (10 mM TCEP) and alkylation 769 (20 mM chloroacetamide)

UHPLC/Thermo QExactuve Plus)

raw files were processed using Mascot (version 2.6.1.100) and searched for 774 protein identification against the SwissProt protein database for human

Search parameters specified an MS tolerance of 10 ppm, an MS/MS tolerance

Da and full trypsin digestion, allowing for up to two missed cleavages. False discovery rate was 780 REFERENCES 810

BEN: a novel domain in chromatin factors 811 and DNA viral proteins

cGAS in action: Expanding roles in immunity and 814 inflammation

Identification of rpo30, a vaccinia 817 virus RNA polymerase gene with structural similarity to a eucaryotic transcription 818 elongation factor

The complete genomic 821 sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses

Vaccinia virus protein 825 K7 is a virulence factor that alters the acute immune response to infection

Structural basis of nucleosome-dependent cGAS inhibition

TRIM14 Inhibits cGAS Degradation Mediated by Selective Autophagy Receptor 833 p62 to Promote Innate Immune Responses

Inhibition of 836 IkappaB kinase by vaccinia virus virulence factor B14

Myxoma virus induces type I interferon 840 production in murine plasmacytoid dendritic cells via a TLR9/MyD88-, IRF5/IRF7-, and 841 IFNAR-dependent pathway

Modified vaccinia virus Ankara triggers type I IFN production in 845 murine conventional dendritic cells via a cGAS/STING-mediated cytosolic DNA-sensing 846 pathway

Intratumoral delivery of inactivated modified 850 vaccinia virus Ankara (iMVA) induces systemic antitumor immunity via STING and Batf3-851 dependent dendritic cells

The BEN 853 domain is a novel sequence-specific DNA-binding domain conserved in neural 854 transcriptional repressors

Effect of aphidicolin on vaccinia virus: isolation of an aphidicolin-857 resistant mutant

Vaccinia virus infection 860 attenuates innate immune responses and antigen presentation by epidermal dendritic cells

Vaccinia virus subverts a mitochondrial antiviral signaling protein-865 dependent innate immune response in keratinocytes through its double-stranded RNA 866 binding protein, E3

DNA sequence variation as a clue to the 869 phylogenesis of orthopoxviruses

Modified vaccinia virus Ankara induces 872 moderate activation of human dendritic cells

Viral and metazoan poxins 875 are cGAMP-specific nucleases that restrict cGAS-STING signalling

Vaccinia virus inhibits the maturation of human dendritic cells: a 879 novel mechanism of immune evasion

Functional dissection of the developmentally restricted BEN domain chromatin 883 boundary factor Insensitive

COVID-19 vaccine 887 candidates based on modified vaccinia virus Ankara expressing the SARS-CoV-2 spike 888 induce robust T-and B-cell immune responses and full efficacy in mice

Virulent 891 Poxviruses Inhibit DNA Sensing by Preventing STING Activation

Essential role of mda-5 in type I IFN responses to 895 polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus

Poxvirus as a vector to 898 transduce human dendritic cells for immunotherapy: abortive infection but reduced APC 899 function

Structural basis for the inhibition of cGAS by nucleosomes

DNA tumor virus oncogenes 906 antagonize the cGAS-STING DNA-sensing pathway

Phosphorylation and 909 chromatin tethering prevent cGAS activation during mitosis

Pivotal roles of cGAS-cGAMP 912 signaling in antiviral defense and immune adjuvant effects

Identification of Poxvirus Genome Uncoating and DNA Replication Factors with Mutually 916 Redundant Roles

One or two 919 injections of MVA-vectored vaccine shields hACE2 transgenic mice from SARS-CoV-2 upper 920 and lower respiratory tract infection

The cGAS-STING Defense Pathway and Its Counteraction by 923 Viruses

The C11R gene, which encodes the vaccinia 926 virus growth factor, is partially responsible for MVA-induced NF-kappaB and ERK2 927 activation

Vaccinia virus uses macropinocytosis and apoptotic 930 mimicry to enter host cells

The Vaccinia virion: Filling the gap between 933 atomic and ultrastructure

Genetic evidence for vaccinia virus-encoded DNA 936 polymerase: isolation of phosphonoacetate-resistant enzyme from the cytoplasm of cells 937 infected with mutant virus

Identification by mass 940 spectroscopy of three major early proteins associated with virosomes in vaccinia virus-941 infected cells

Quantitative proteomics 944 reveal a feedforward mechanism for mitochondrial PARKIN translocation and ubiquitin 945 chain synthesis

Phase 3 Efficacy Trial of Modified Vaccinia 949 Ankara as a Vaccine against Smallpox

Ku80 removal from DNA through double strand break-induced ubiquitylation

Purification and identification of a 956 vaccinia virus-encoded intermediate stage promoter-specific transcription factor that has 957 homology to eukaryotic transcription factor SII (TFIIS) and an additional role as a viral 958 RNA polymerase subunit

A modified vaccinia Ankara vector-962 based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and 963 dysfunction in the lungs

A BEN-966 domain-containing protein associates with heterochromatin and represses transcription

The N-ethyl-N-nitrosourea-971 induced Goldenticket mouse mutant reveals an essential function of Sting in the in vivo 972 interferon response to Listeria monocytogenes and cyclic dinucleotides

Pan-viral specificity of IFN-induced 977 genes reveals new roles for cGAS in innate immunity

TRIM56-mediated 980 monoubiquitination of cGAS for cytosolic DNA sensing

The DNA Sensor cGAS is 983 Decorated by Acetylation and Phosphorylation Modifications in the Context of Immune 984 Signaling

The 987 orthopoxvirus 68-kilodalton ankyrin-like protein is essential for DNA replication and 988 complete gene expression of modified vaccinia virus Ankara in nonpermissive human and 989 murine cells

Nonreplicating vaccinia vector efficiently expresses 992 recombinant genes

Vaccinia virus encodes a soluble type I 995 interferon receptor of novel structure and broad species specificity

Immunogenicity and efficacy of the COVID-999 19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination

Modified Vaccinia Virus Ankara: History, Value in Basic 1003 Research, and Current Perspectives for Vaccine Development

The E3 ubiquitin ligase RNF185 facilitates the cGAS-mediated innate immune 1007 response

Dephosphorylation of the RNA sensors RIG-I and MDA5 by the phosphatase PP1 is essential 1011 for innate immune signaling

Resistance to 1014 ectromelia virus infection requires cGAS in bone marrow-derived cells which can be 1015 bypassed with cGAMP therapy

Cyclic GMP-AMP is an 1018 endogenous second messenger in innate immune signaling by cytosolic DNA

Inhibition of cGAS DNA Sensing by a Herpesvirus Virion Protein. Cell host & 1023 microbe

Role of Post-Translational Modifications of cGAS in Innate 1026 Immunity

cGAS is essential for cellular 1029 senescence

Simultaneous high-1032 resolution analysis of vaccinia virus and host cell transcriptomes by deep RNA sequencing

Cytoplasmic isoforms of Kaposi sarcoma 1036 herpesvirus LANA recruit and antagonize the innate immune DNA sensor cGAS